Corcept Therapeutics Inc (CORT) insider trading

Every open-market stock purchase and sale by Corcept Therapeutics Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • Sean Maduck (Insider) and 8 others sold $53.9M in the last 90 days.
  • Last insider buy: G Leonard Baker Jr (Insider), $2.5M, 7 months ago.

Last 12 months: insiders bought $3.3M (1 buy) and sold $102M (52 sales). Last close $116.28 on Oct 21, 2026.

Recent CORT insider trades

DateInsiderTradeValue
Oct 15, 2026James N Wilson (Insider)Sold$762K
Oct 15, 2026James N Wilson (Insider)Sold$351K
Oct 15, 2026James N Wilson (Insider)Sold$34.9K
Oct 2, 2026Sean Maduck (Insider)Sold$1.8M
Oct 2, 2026Sean Maduck (Insider)Sold$1M
Oct 2, 2026Roberto Wandenkolk Vieira (President)Sold$600K
Oct 2, 2026Joseph Douglas Lyon (Insider)Sold$553K
Oct 2, 2026Joseph Douglas Lyon (Insider)Sold$514K
Oct 2, 2026Roberto Wandenkolk Vieira (President)Sold$241K
Oct 2, 2026Sean Maduck (Insider)Bought (not open market)$203K
Oct 2, 2026Roberto Wandenkolk Vieira (President)Bought (not open market)$180K
Oct 2, 2026Roberto Wandenkolk Vieira (President)Sold$126K
Oct 2, 2026Joseph Douglas Lyon (Insider)Bought (not open market)$112K
Oct 2, 2026Joseph Douglas Lyon (Insider)Bought (not open market)$45.5K
Oct 2, 2026Joseph Douglas Lyon (Insider)Bought (not open market)—
Oct 2, 2026Roberto Wandenkolk Vieira (President)Bought (not open market)—
Oct 2, 2026Joseph Douglas Lyon (Insider)Bought (not open market)—
Oct 2, 2026Sean Maduck (Insider)Bought (not open market)—
Oct 1, 2026Joseph Douglas Lyon (Insider)Sold$93.5K
Oct 1, 2026Sean Maduck (Insider)Sold$47.7K
Oct 1, 2026Joseph Douglas Lyon (Insider)Bought (not open market)$11K
Oct 1, 2026Sean Maduck (Insider)Bought (not open market)$3.4K
Oct 1, 2026Joseph Douglas Lyon (Insider)Bought (not open market)—
Oct 1, 2026Sean Maduck (Insider)Bought (not open market)—
Oct 1, 2026Justin Frederick Gunn (Insider)Bought (not open market)—

Who's trading CORT

Get free alerts when an insider at Corcept Therapeutics Inc files a new trade →